Skip to Content

Fludarabine Pregnancy and Breastfeeding Warnings

Fludarabine is also known as: Fludara, Oforta

Fludarabine Pregnancy Warnings

Fludarabine has been assigned to pregnancy category D by the FDA. Animal data have revealed evidence teratogenicity (increased incidence of various skeletal malformations and external deformities) and embryolethality. There are no data from controlled human pregnancy studies. Fludarabine may cause fetal harm when administered to a pregnant woman. If fludarabine is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Women of childbearing potential should be advised to avoid becoming pregnant. Fludarabine is considered contraindicated during pregnancy.

See references

Fludarabine Breastfeeding Warnings

There are no data on the excretion of fludarabine into human milk. Because many drugs are excreted into human milk and because of the potential for serious adverse reactions in nursing infants from this drug, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug for the mother.

See references

References for pregnancy information

  1. "Product Information. Fludara (fludarabine)." Berlex, Richmond, CA.

References for breastfeeding information

  1. "Product Information. Fludara (fludarabine)." Berlex, Richmond, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.